peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
SPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LSSPATLDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (57%);2.5.1.7 (14%);2.7.13.3 (14%),Pyridoxal kinase (57%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (14%);Histidine kinase (14%),GO:0005615 (86%);GO:0005737 (19%);GO:0032991 (9%),extracellular space (86%);cytoplasm (19%);protein-containing complex (9%),GO:0046872 (43%);GO:0005504 (14%);GO:0003677 (9%),metal ion binding (43%);fatty acid binding (14%);DNA binding (9%),GO:0001542 (13%);GO:0042448 (13%);GO:0060395 (13%),ovulation from ovarian follicle (13%);progesterone metabolic process (13%);SMAD protein signal transduction (13%),IPR000264 (90%);IPR014760 (90%);IPR020858 (90%),ALB/AFP/VDB (90%);Serum albumin, N-terminal (90%);Serum albumin-like (90%)
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
LSSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.1 (75%);2.7.9.2 (25%),Sarcosine oxidase (75%);Pyruvate, water dikinase (25%),GO:0005737 (60%);GO:0031463 (20%),cytoplasm (60%);Cul3-RING ubiquitin ligase complex (20%),GO:0008115 (60%);GO:0005524 (20%);GO:0008986 (20%),sarcosine oxidase activity (60%);ATP binding (20%);pyruvate, water dikinase activity (20%),GO:0046653 (60%);GO:0006090 (20%);GO:0006094 (20%),tetrahydrofolate metabolic process (60%);pyruvate metabolic process (20%);gluconeogenesis (20%),IPR006222 (50%);IPR006277 (50%);IPR013977 (50%),Aminomethyltransferase, folate-binding domain (50%);Sarcosine oxidase, alpha subunit (50%);Glycine cleavage T-protein, C-terminal barrel domain (50%)
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
VAEVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
AEYEDLATR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLNAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVDLAAYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLTVSLPR,Dikarya,Eukaryota,Fungi,Dikarya,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0031307 (100%),integral component of mitochondrial outer membrane (100%),GO:0001671 (100%);GO:0031072 (100%);GO:0046872 (100%),ATPase activator activity (100%);heat shock protein binding (100%);metal ion binding (100%),GO:0006457 (100%);GO:0030150 (100%),protein folding (100%);protein import into mitochondrial matrix (100%),IPR001305 (50%);IPR001623 (50%);IPR001810 (50%),Heat shock protein DnaJ, cysteine-rich domain (50%);DnaJ domain (50%);F-box domain (50%)
VTVNLGGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CNSGAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHMLHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0051301 (80%),cell division (80%),IPR001182 (100%),Probable peptidoglycan glycosyltransferase FtsW/RodA (100%)
NYLYWNHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGAYK,Eubacteriales,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,,,,,,,,,,,,,,,5.3.1.9 (100%),Glucose-6-phosphate isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004347 (100%),glucose-6-phosphate isomerase activity (100%),GO:0006094 (100%);GO:0006096 (100%),gluconeogenesis (100%);glycolytic process (100%),IPR010551 (100%);IPR011051 (100%);IPR014710 (100%),Glucose-6-phosphate isomerase, prokaryote (100%);RmlC-like cupin domain superfamily (100%);RmlC-like jelly roll fold (100%)
EATVLLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),,,GO:0003677 (100%);GO:0003899 (40%);GO:0046983 (40%),DNA binding (100%);DNA-directed 5'-3' RNA polymerase activity (40%);protein dimerization activity (40%),GO:0006351 (40%),transcription, DNA-templated (40%),IPR010093 (43%);IPR041657 (43%);IPR011260 (29%),SinI-like, DNA-binding domain (43%);Helix-turn-helix domain, group 17 (43%);RNA polymerase, alpha subunit, C-terminal (29%)
DMLGYAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.205 (100%),IMP dehydrogenase (100%),GO:0005840 (71%);GO:0016021 (14%);GO:0005737 (7%),ribosome (71%);integral component of membrane (14%);cytoplasm (7%),GO:0003735 (71%);GO:0019843 (71%);GO:0000166 (7%),structural constituent of ribosome (71%);rRNA binding (71%);nucleotide binding (7%),GO:0006412 (71%);GO:0006177 (7%);GO:0006313 (7%),translation (71%);GMP biosynthetic process (7%);transposition, DNA-mediated (7%),IPR000876 (71%);IPR002942 (71%);IPR013843 (71%),Ribosomal protein S4e (71%);RNA-binding S4 domain (71%);Ribosomal protein S4e, N-terminal (71%)
HFPMHLYHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWETGTAEEFANR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HFPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLYWNHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLYHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (80%);2.5.1.15 (7%);6.1.1.19 (1%),Proline--tRNA ligase (80%);Dihydropteroate synthase (7%);Arginine--tRNA ligase (1%),GO:0005737 (41%);GO:0005634 (31%);GO:0016021 (13%),cytoplasm (41%);nucleus (31%);integral component of membrane (13%),GO:0005524 (37%);GO:0008270 (35%);GO:0004827 (32%),ATP binding (37%);zinc ion binding (35%);proline-tRNA ligase activity (32%),GO:0003323 (34%);GO:0050796 (34%);GO:0070365 (34%),type B pancreatic cell development (34%);regulation of insulin secretion (34%);hepatocyte differentiation (34%),IPR000536 (32%);IPR035500 (32%);IPR001723 (32%),Nuclear hormone receptor, ligand-binding domain (32%);Nuclear hormone receptor-like domain superfamily (32%);Nuclear hormone receptor (32%)
MSMPLVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVDHDNDMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSMMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYWHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWYHLFVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPQMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLAACVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (64%);2.7.7.6 (14%);1.8.4.11 (7%),Glycine--tRNA ligase (64%);DNA-directed RNA polymerase (14%);Peptide-methionine (S)-S-oxide reductase (7%),GO:0005737 (41%);GO:0016021 (7%);GO:0000502 (4%),cytoplasm (41%);integral component of membrane (7%);proteasome complex (4%),GO:0003677 (41%);GO:0005524 (37%);GO:0004820 (33%),DNA binding (41%);ATP binding (37%);glycine-tRNA ligase activity (33%),GO:0006426 (33%);GO:0006351 (7%);GO:0009405 (7%),glycyl-tRNA aminoacylation (33%);transcription, DNA-templated (7%);obsolete pathogenesis (7%),IPR002315 (33%);IPR004154 (33%);IPR006195 (33%),Glycyl-tRNA synthetase (33%);Anticodon-binding (33%);Aminoacyl-tRNA synthetase, class II (33%)
APESHLYHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLWPGSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAMLLLLMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTK,Dorea,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,Lachnospiraceae,,,,Dorea,,,,,,,,,,,,,,,,,,IPR001453 (100%);IPR036425 (100%),MoaB/Mog domain (100%);MoaB/Mog-like domain superfamily (100%)
RPMHLYHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYYGHLTAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDTEWMNLLSDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GAATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.1 (23%);4.2.99.18 (6%);5.6.2.2 (6%),Transketolase (23%);DNA-(apurinic or apyrimidinic site) lyase (6%);DNA topoisomerase (ATP-hydrolyzing) (6%),GO:0016021 (23%);GO:0005634 (13%);GO:0005737 (5%),integral component of membrane (23%);nucleus (13%);cytoplasm (5%),GO:0005524 (13%);GO:0003677 (12%);GO:0046872 (11%),ATP binding (13%);DNA binding (12%);metal ion binding (11%),GO:0007049 (7%);GO:0006397 (2%);GO:0006310 (2%),cell cycle (7%);mRNA processing (2%);DNA recombination (2%),IPR027417 (9%);IPR024974 (5%);IPR029071 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Sde2, N-terminal ubiquitin domain (5%);Ubiquitin-like domain superfamily (5%)
LTQASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.52 (8%);4.1.2.4 (8%);1.13.11.- (5%),Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (8%);Deoxyribose-phosphate aldolase (8%);With incorporation of two atoms of oxygen (5%),GO:0016021 (34%);GO:0005886 (14%);GO:0005737 (8%),integral component of membrane (34%);plasma membrane (14%);cytoplasm (8%),GO:0005524 (9%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (9%);metal ion binding (9%);DNA binding (8%),GO:0007165 (6%);GO:0030150 (6%);GO:0042121 (4%),signal transduction (6%);protein import into mitochondrial matrix (6%);alginic acid biosynthetic process (4%),IPR016024 (16%);IPR007483 (16%);IPR027417 (6%),Armadillo-type fold (16%);Hamartin (16%);P-loop containing nucleoside triphosphate hydrolase (6%)
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
GSGGGSSGGSLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (53%);GO:0001533 (44%),keratin filament (100%);plasma membrane (53%);cornified envelope (44%),GO:0046982 (47%);GO:0030246 (44%);GO:0030280 (44%),protein heterodimerization activity (47%);carbohydrate binding (44%);structural constituent of skin epidermis (44%),GO:0050728 (47%);GO:0051290 (47%);GO:0061436 (47%),negative regulation of inflammatory response (47%);protein heterotetramerization (47%);establishment of skin barrier (47%),IPR032449 (100%);IPR003054 (97%);IPR039008 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament, rod domain (97%)
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (50%);3.5.99.2 (50%),Electron-transferring-flavoprotein dehydrogenase (50%);Aminopyrimidine aminohydrolase (50%),GO:0045095 (92%);GO:0005886 (47%);GO:0001533 (37%),keratin filament (92%);plasma membrane (47%);cornified envelope (37%),GO:0030280 (37%);GO:0046982 (36%);GO:0030246 (35%),structural constituent of skin epidermis (37%);protein heterodimerization activity (36%);carbohydrate binding (35%),GO:0018149 (37%);GO:0051290 (36%);GO:0001867 (35%),peptide cross-linking (37%);protein heterotetramerization (36%);complement activation, lectin pathway (35%),IPR032444 (92%);IPR003054 (91%);IPR039008 (91%),Keratin type II head (92%);Keratin, type II (91%);Intermediate filament, rod domain (91%)
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
VLPLLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.2 (33%);6.3.4.19 (33%);7.1.1.2 (33%),Acid phosphatase (33%);tRNA(Ile)-lysidine synthetase (33%);NADH:ubiquinone reductase (H(+)-translocating) (33%),GO:0016021 (67%);GO:0005737 (3%);GO:0005739 (1%),integral component of membrane (67%);cytoplasm (3%);mitochondrion (1%),GO:0016787 (21%);GO:0016829 (5%);GO:0000287 (3%),hydrolase activity (21%);lyase activity (5%);magnesium ion binding (3%),GO:0000160 (1%);GO:0002224 (1%);GO:0002755 (1%),phosphorelay signal transduction system (1%);toll-like receptor signaling pathway (1%);MyD88-dependent toll-like receptor signaling pathway (1%),IPR016024 (41%);IPR011989 (40%);IPR004155 (38%),Armadillo-type fold (41%);Armadillo-like helical (40%);PBS lyase HEAT-like repeat (38%)
SPPRPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.22 (33%);2.4.1.258 (17%);2.7.11.1 (17%),Cyclin-dependent kinase (33%);Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichol alpha-1,3-mannosyltransferase (17%);Non-specific serine/threonine protein kinase (17%),GO:0005634 (12%);GO:0016021 (11%);GO:0005912 (9%),nucleus (12%);integral component of membrane (11%);adherens junction (9%),GO:0005524 (69%);GO:0004672 (67%);GO:0008013 (9%),ATP binding (69%);protein kinase activity (67%);beta-catenin binding (9%),GO:0001824 (10%);GO:0007088 (10%);GO:2001234 (10%),blastocyst development (10%);regulation of mitotic nuclear division (10%);negative regulation of apoptotic signaling pathway (10%),IPR000719 (63%);IPR011009 (63%);IPR008271 (61%),Protein kinase domain (63%);Protein kinase-like domain superfamily (63%);Serine/threonine-protein kinase, active site (61%)
LLLPFNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.2.- (33%);3.2.2.0 (33%);3.2.2.4 (33%),Sulfotransferases (33%); (33%);AMP nucleosidase (33%),GO:0016021 (36%);GO:0000139 (7%);GO:0005765 (7%),integral component of membrane (36%);Golgi membrane (7%);lysosomal membrane (7%),GO:0004553 (14%);GO:0016740 (14%);GO:0030246 (14%),hydrolase activity, hydrolyzing O-glycosyl compounds (14%);transferase activity (14%);carbohydrate binding (14%),GO:0005975 (14%);GO:0009691 (7%);GO:0016051 (7%),carbohydrate metabolic process (14%);cytokinin biosynthetic process (7%);carbohydrate biosynthetic process (7%),IPR012808 (42%);IPR015996 (42%);IPR031100 (21%),Conserved hypothetical protein CHP02453 (42%);Uncharacterised conserved protein UCP028451 (42%);LOG family (21%)
VGKPVVAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSLNSLHSLFF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (12%);3.6.4.- (7%);4.3.1.19 (7%),Acting on ester bonds (12%);Acting on ATP; involved in cellular and subcellular movement (7%);Threonine ammonia-lyase (7%),GO:0016021 (18%);GO:0005737 (9%);GO:0005886 (6%),integral component of membrane (18%);cytoplasm (9%);plasma membrane (6%),GO:0003677 (17%);GO:0005524 (11%);GO:0046872 (9%),DNA binding (17%);ATP binding (11%);metal ion binding (9%),GO:0000160 (6%);GO:0006355 (6%);GO:0005975 (5%),phosphorelay signal transduction system (6%);regulation of transcription, DNA-templated (6%);carbohydrate metabolic process (5%),IPR012486 (8%);IPR040185 (8%);IPR021819 (8%),Far11/STRP, N-terminal (8%);Far11/STRP (8%);Far11/STRP, C-terminal (8%)
YSATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.14 (18%);2.4.1.1 (8%);5.4.99.12 (8%),Chitinase (18%);Glycogen phosphorylase (8%);tRNA pseudouridine(38-40) synthase (8%),GO:0016021 (52%);GO:0005886 (43%);GO:0005737 (7%),integral component of membrane (52%);plasma membrane (43%);cytoplasm (7%),GO:0046872 (45%);GO:0046873 (43%);GO:0015293 (41%),metal ion binding (45%);metal ion transmembrane transporter activity (43%);symporter activity (41%),GO:0006412 (4%);GO:0006397 (2%);GO:0008380 (2%),translation (4%);mRNA processing (2%);RNA splicing (2%),IPR001046 (39%);IPR013819 (5%);IPR036226 (5%),NRAMP family (39%);Lipoxygenase, C-terminal (5%);Lipoxigenase, C-terminal domain superfamily (5%)
HDVMTAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (97%);2.3.1.20 (1%);2.3.3.14 (1%),3-methyl-2-oxobutanoate hydroxymethyltransferase (97%);Diacylglycerol O-acyltransferase (1%);Homocitrate synthase (1%),GO:0005737 (74%);GO:0016021 (2%);GO:0005886 (1%),cytoplasm (74%);integral component of membrane (2%);plasma membrane (1%),GO:0046872 (86%);GO:0003864 (74%);GO:0008168 (72%),metal ion binding (86%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (74%);methyltransferase activity (72%),GO:0015940 (74%);GO:0032259 (72%);GO:0045892 (4%),pantothenate biosynthetic process (74%);methylation (72%);negative regulation of transcription, DNA-templated (4%),IPR003700 (73%);IPR015813 (73%);IPR040442 (73%),Ketopantoate hydroxymethyltransferase (73%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (73%);Pyruvate kinase-like domain superfamily (73%)
ARPLLQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.4 (50%);2.7.1.71 (25%);6.1.1.7 (25%),Adenosine deaminase (50%);Shikimate kinase (25%);Alanine--tRNA ligase (25%),GO:0016021 (25%);GO:0005615 (10%);GO:0005737 (10%),integral component of membrane (25%);extracellular space (10%);cytoplasm (10%),GO:0005524 (20%);GO:0016491 (20%);GO:0004000 (10%),ATP binding (20%);oxidoreductase activity (20%);adenosine deaminase activity (10%),GO:0006154 (10%);GO:0006629 (8%);GO:0006631 (8%),adenosine catabolic process (10%);lipid metabolic process (8%);fatty acid metabolic process (8%),IPR036291 (13%);IPR027417 (12%);IPR010753 (10%),NAD(P)-binding domain superfamily (13%);P-loop containing nucleoside triphosphate hydrolase (12%);Domain of unknown function DUF1330 (10%)
VGRPYLDK,Tanacetum cinerariifolium,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,Asterales,,,,Asteraceae,Asteroideae,Anthemideae,Anthemidinae,Tanacetum,,,,Tanacetum cinerariifolium,,,,,,,,,,GO:0003964 (100%),RNA-directed DNA polymerase activity (100%),,,IPR000477 (100%);IPR043128 (100%);IPR043502 (100%),Reverse transcriptase domain (100%);Reverse transcriptase/Diguanylate cyclase domain (100%);DNA/RNA polymerase superfamily (100%)
NPFLALLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (33%),integral component of membrane (100%);plasma membrane (33%),GO:0008324 (33%);GO:0015450 (33%);GO:0015562 (33%),cation transmembrane transporter activity (33%);P-P-bond-hydrolysis-driven protein transmembrane transporter activity (33%);efflux transmembrane transporter activity (33%),GO:0006886 (33%),intracellular protein transport (33%),IPR001036 (100%);IPR003423 (50%);IPR004763 (50%),Acriflavin resistance protein (100%);Outer membrane efflux protein (50%);Cation efflux system CzcA/CusA/SilA/NccA/HelA/CnrA (50%)
LTLSGGSFTATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TASRPLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (50%);2.5.1.141 (50%),Pyruvate dehydrogenase (acetyl-transferring) (50%);Heme o synthase (50%),GO:0016021 (71%);GO:0005739 (14%);GO:0005840 (14%),integral component of membrane (71%);mitochondrion (14%);ribosome (14%),GO:0016758 (43%);GO:0003735 (14%);GO:0004739 (14%),hexosyltransferase activity (43%);structural constituent of ribosome (14%);pyruvate dehydrogenase (acetyl-transferring) activity (14%),GO:0006086 (14%);GO:0006412 (14%);GO:0048034 (14%),acetyl-CoA biosynthetic process from pyruvate (14%);translation (14%);heme O biosynthetic process (14%),IPR018584 (50%);IPR000537 (17%);IPR001017 (17%),Glycosyltransferase family 87 (50%);UbiA prenyltransferase family (17%);Dehydrogenase, E1 component (17%)
AANSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.38 (12%);2.7.1.40 (7%);2.7.13.3 (7%),Malate dehydrogenase (oxaloacetate-decarboxylating) (12%);Pyruvate kinase (7%);Histidine kinase (7%),GO:0005737 (27%);GO:0016021 (18%);GO:0005634 (4%),cytoplasm (27%);integral component of membrane (18%);nucleus (4%),GO:0003677 (32%);GO:0004519 (26%);GO:0005524 (8%),DNA binding (32%);endonuclease activity (26%);ATP binding (8%),GO:0006298 (24%);GO:0006304 (23%);GO:0006412 (3%),mismatch repair (24%);DNA modification (23%);translation (3%),IPR011335 (19%);IPR037057 (19%);IPR011337 (19%),Restriction endonuclease  type II-like (19%);DNA mismatch repair MutH/Restriction endonuclease, type II superfamily (19%);DNA mismatch repair MutH/Restriction endonuclease, type II (19%)
LDALAAWADK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGAFVVLQQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR006517 (100%);IPR035421 (33%),Archaeophage PsiM2, terminase large subunit (100%);Terminase, large subunit gp17-like, C-terminal (33%)
QLVVPKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDGLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (76%);2.1.1.290 (4%);2.3.1.231 (4%),Dihydrolipoyl dehydrogenase (76%);tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase (4%);tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)methoxycarbonyltransferase (4%),GO:0016021 (19%);GO:0005886 (5%);GO:0016020 (5%),integral component of membrane (19%);plasma membrane (5%);membrane (5%),GO:0005524 (39%);GO:0004672 (30%);GO:0050660 (18%),ATP binding (39%);protein kinase activity (30%);flavin adenine dinucleotide binding (18%),GO:0045454 (16%);GO:0006355 (6%);GO:0006811 (5%),cell redox homeostasis (16%);regulation of transcription, DNA-templated (6%);ion transport (5%),IPR011009 (29%);IPR000719 (28%);IPR001245 (24%),Protein kinase-like domain superfamily (29%);Protein kinase domain (28%);Serine-threonine/tyrosine-protein kinase, catalytic domain (24%)
DVATTMLEGLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,